{"id":"https://openalex.org/W2097704243","doi":null,"title":"Antitumor spectrum of a new anthracycline, (2\"R)-4'-O-tetrahydropyranyladriamycin, and effect on the cellular immune response in mice.","display_name":"Antitumor spectrum of a new anthracycline, (2\"R)-4'-O-tetrahydropyranyladriamycin, and effect on the cellular immune response in mice.","publication_year":1985,"publication_date":"1985-10-01","ids":{"openalex":"https://openalex.org/W2097704243","mag":"2097704243","pmid":"https://pubmed.ncbi.nlm.nih.gov/3935619"},"language":"en","primary_location":{"id":"pmid:3935619","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3935619","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese journal of cancer research : Gann","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"T Hisamatsu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405275510","display_name":"Meiji Seika Pharma Co., Ltd. (Japan)","ror":"https://ror.org/03qt4xn36","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405275510"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"T Hisamatsu","raw_affiliation_strings":["Pharmacology and Toxicology Laboratories, Meiji Seika Kaisha Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology and Toxicology Laboratories, Meiji Seika Kaisha Ltd","institution_ids":["https://openalex.org/I4405275510"]}]},{"author_position":"middle","author":{"id":null,"display_name":"K Suzuki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405275510","display_name":"Meiji Seika Pharma Co., Ltd. (Japan)","ror":"https://ror.org/03qt4xn36","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405275510"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"K Suzuki","raw_affiliation_strings":["Pharmacology and Toxicology Laboratories, Meiji Seika Kaisha Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology and Toxicology Laboratories, Meiji Seika Kaisha Ltd","institution_ids":["https://openalex.org/I4405275510"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068919188","display_name":"Shiro Sakakibara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405275510","display_name":"Meiji Seika Pharma Co., Ltd. (Japan)","ror":"https://ror.org/03qt4xn36","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405275510"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"S Sakakibara","raw_affiliation_strings":["Pharmacology and Toxicology Laboratories, Meiji Seika Kaisha Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology and Toxicology Laboratories, Meiji Seika Kaisha Ltd","institution_ids":["https://openalex.org/I4405275510"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021691317","display_name":"Keiko Komuro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405275510","display_name":"Meiji Seika Pharma Co., Ltd. (Japan)","ror":"https://ror.org/03qt4xn36","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405275510"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"K Komuro","raw_affiliation_strings":["Pharmacology and Toxicology Laboratories, Meiji Seika Kaisha Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology and Toxicology Laboratories, Meiji Seika Kaisha Ltd","institution_ids":["https://openalex.org/I4405275510"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035393256","display_name":"Mieko Nagasawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405275510","display_name":"Meiji Seika Pharma Co., Ltd. (Japan)","ror":"https://ror.org/03qt4xn36","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405275510"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"M Nagasawa","raw_affiliation_strings":["Pharmacology and Toxicology Laboratories, Meiji Seika Kaisha Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology and Toxicology Laboratories, Meiji Seika Kaisha Ltd","institution_ids":["https://openalex.org/I4405275510"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103855412","display_name":"TOMIO TAKEUCHI","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Takeuchi","raw_affiliation_strings":["Institute of Microbial Chemistry"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Microbial Chemistry","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103423333","display_name":"HAMAO UMEZAWA","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Umezawa","raw_affiliation_strings":["Institute of Microbial Chemistry"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Microbial Chemistry","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6107,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.67136294,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"76","issue":"10","first_page":"1008","last_page":"20"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.5321999788284302,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.5321999788284302,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.41359999775886536,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.01549999974668026,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anthracyclines","display_name":"anthracyclines","score":0.7879999876022339},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.8560000061988831},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.9950000047683716},{"id":"https://openalex.org/keywords/cell-mediated-immunity","display_name":"cell-mediated immunity","score":0.6299999952316284},{"id":"https://openalex.org/keywords/p388-leukemia","display_name":"P388 leukemia","score":0.7080000042915344},{"id":"https://openalex.org/keywords/meth-a-sarcoma","display_name":"Meth A fibrosarcoma","score":0.9039999842643738},{"id":"https://openalex.org/keywords/l1210-lymphoma","display_name":"L1210 lymphoma","score":0.8510000109672546},{"id":"https://openalex.org/keywords/yoshida-sarcoma","display_name":"Yoshida sarcoma","score":0.9729999899864197},{"id":"https://openalex.org/keywords/doxorubicin-resistance","display_name":"doxorubicin resistance","score":0.8600000143051147},{"id":"https://openalex.org/keywords/tumor-bearing-mice","display_name":"tumor-bearing mice","score":0.7149999737739563}],"concepts":[{"id":"https://openalex.org/C2776495794","wikidata":"https://www.wikidata.org/wiki/Q1362453","display_name":"Fibrosarcoma","level":2,"score":0.8431609869003296},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.7835143804550171},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.777268648147583},{"id":"https://openalex.org/C2777928079","wikidata":"https://www.wikidata.org/wiki/Q2677027","display_name":"Rat\u00f3n","level":2,"score":0.5670850276947021},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.5561997294425964},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4653495252132416},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4509826898574829},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.42364758253097534},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.39475953578948975},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3755109906196594},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33807843923568726},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2976266145706177},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2477145493030548},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.19629034399986267},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.16750013828277588},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007111","descriptor_name":"Immunity, Cellular","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007939","descriptor_name":"Leukemia L1210","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007941","descriptor_name":"Leukemia P388","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008325","descriptor_name":"Mammary Neoplasms, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008815","descriptor_name":"Mice, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012517","descriptor_name":"Sarcoma, Yoshida","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:3935619","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3935619","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese journal of cancer research : Gann","raw_type":"Journal Article"},{"id":"mag:2097704243","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3935619","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":13,"referenced_works":["https://openalex.org/W57780008","https://openalex.org/W1594230811","https://openalex.org/W1604212800","https://openalex.org/W1947696988","https://openalex.org/W1980403316","https://openalex.org/W1993637374","https://openalex.org/W2013442656","https://openalex.org/W2051201030","https://openalex.org/W2073538067","https://openalex.org/W2126163454","https://openalex.org/W2148781593","https://openalex.org/W2346494687","https://openalex.org/W2472512738"],"related_works":["https://openalex.org/W1983370624","https://openalex.org/W1947696988","https://openalex.org/W2095461916","https://openalex.org/W2065117226","https://openalex.org/W2417392416","https://openalex.org/W2313026141","https://openalex.org/W2199811944","https://openalex.org/W2508320953","https://openalex.org/W2415029639","https://openalex.org/W1043795871"],"abstract_inverted_index":{"(2''R)-4'-O-Tetrahydropyranyladriamycin":[0],"(THP),":[1],"a":[2],"new":[3],"anthracycline":[4],"antibiotic,":[5],"showed":[6],"stronger":[7],"inhibition":[8],"of":[9,12,30,45,55],"the":[10,59,71],"growth":[11],"L1210,":[13],"CCMT":[14],"(mouse":[15,36],"mammary":[16],"adenocarcinoma)":[17],"and":[18,34,77],"Yoshida":[19],"sarcoma":[20],"in":[21,75],"rats":[22],"than":[23],"did":[24],"adriamycin":[25],"(ADM).":[26],"The":[27],"antitumor":[28],"activity":[29],"THP":[31,48,57],"against":[32,51,63],"P388":[33],"Meth-A":[35],"fibrosarcoma)":[37],"was":[38,49],"equal":[39],"or":[40],"slightly":[41],"superior":[42],"to":[43],"that":[44],"ADM.":[46],"Moreover,":[47],"active":[50],"an":[52],"ADM-resistant":[53],"subline":[54],"P388.":[56],"at":[58],"optimal":[60],"effective":[61],"dose":[62],"experimental":[64],"tumors":[65],"had":[66],"no":[67],"toxic":[68],"effect":[69],"on":[70],"cellular":[72],"immune":[73],"system":[74],"normal":[76],"tumor-bearing":[78],"mice.":[79]},"counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}